Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Madiha Saeed, Fang‐Ming Chen, Jiayi Ye, et al.
Advanced Materials (2021) Vol. 33, Iss. 30
Open Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer
Fengqi Zhou, Jing Gao, Yang Tang, et al.
Advanced Materials (2021) Vol. 33, Iss. 43
Open Access | Times Cited: 51
Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
Jiayi Ye, Bo Hou, Fangmin Chen, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 6, pp. 2695-2709
Open Access | Times Cited: 41
Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy
Junhao Li, Lujia Huang, Huiling Zhou, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 11, pp. 2749-2758
Open Access | Times Cited: 36
Engineered anti-cancer nanomedicine for synergistic ferroptosis-immunotherapy
Xinyu Zhang, Haiyan Ge, Yanling Ma, et al.
Chemical Engineering Journal (2022) Vol. 455, pp. 140688-140688
Closed Access | Times Cited: 33
Bioinspired Lipoproteins of Furoxans–Oxaliplatin Remodel Physical Barriers in Tumor to Potentiate T‐Cell Infiltration
Haijun Yu, Honglei Xie, Yao Wu, et al.
Advanced Materials (2022) Vol. 34, Iss. 14
Closed Access | Times Cited: 31
Tumor Microenvironment‐Activated Nanocomposite for Self‐Amplifying Chemodynamic/Starvation Therapy Enhanced IDO‐Blockade Tumor Immunotherapy
Yulong Bian, Bin Liu, Binbin Ding, et al.
Advanced Science (2023) Vol. 10, Iss. 34
Open Access | Times Cited: 21
Carbon Dots and Tumor Antigen Conjugates as Nanovaccines for Elevated Cancer Immunotherapy
Hongxin Liu, Zhigang Xie, Min Zheng
Small (2023) Vol. 19, Iss. 31
Closed Access | Times Cited: 20
Role of Micelle Size in Cell Transcytosis-Based Tumor Extravasation, Infiltration, and Treatment Efficacy
Wufa Fan, Jiajia Xiang, Qiuyu Wei, et al.
Nano Letters (2023) Vol. 23, Iss. 9, pp. 3904-3912
Closed Access | Times Cited: 19
Engineering cells for therapy and diagnosis
Zhaoting Li, Yixin Wang, Zhen Gu, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 9, pp. 770-784
Closed Access | Times Cited: 7
An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells
Siyu Meng, Huiping Du, Xiang Li, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3134-3150
Closed Access | Times Cited: 6
Unprecedented Chiral Nanovaccines for Significantly Enhanced Cancer Immunotherapy
Hongxin Liu, Zhigang Xie, Min Zheng
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 35, pp. 39858-39865
Closed Access | Times Cited: 26
Bacteria-mediated metformin-loaded peptide hydrogel reprograms the tumor immune microenvironment in glioblastoma
Lisheng Zhu, Jingyu Liu, Meng-jun Qiu, et al.
Biomaterials (2022) Vol. 288, pp. 121711-121711
Open Access | Times Cited: 22
Recombinant humanized collagen type III with high antitumor activity inhibits breast cancer cells autophagy, proliferation, and migration through DDR1
Xiaowei Liu, Hu Li, Tingrui Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 243, pp. 125130-125130
Open Access | Times Cited: 14
Fe-doped carbon dots: a novel biocompatible nanoplatform for multi-level cancer therapy
Mingxi Yang, Haiqiu Li, Xinchen Liu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Liposomal celecoxib combined with dendritic cell therapy enhances antitumor efficacy in melanoma
Vajiheh Jahani, Mona Yazdani, Ali Badiee, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 453-464
Closed Access | Times Cited: 13
Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T1-magnetic resonance imaging
Yike Hou, Fei Kong, Zhe Tang, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 547-563
Closed Access | Times Cited: 5
Biomimetic gold nano-modulator for deep-tumor NIR-II photothermal immunotherapy via gaseous microenvironment remodeling strategy
Honglin Huang, Zhengxin Xie, Ningxi Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: Therapeutic strategies and insights
Hanie Mahaki, Sima Nobari, Hamid Tanzadehpanah, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118023-118023
Closed Access
Engineering Bioinspired Nanomedicines to Mitigate the Resistance to Cancer Immunotherapy
Jiayi Ye, Bo Hou, Madiha Saeed, et al.
Accounts of Materials Research (2022) Vol. 3, Iss. 7, pp. 697-708
Closed Access | Times Cited: 21
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma
Fenglin Li, Yi Lai, Jiayi Ye, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3486-3497
Open Access | Times Cited: 19
Rationally Integrated Precise ER‐Targeted and Oxygen‐Compensated Photodynamic Immunostimulant for Immunogenicity‐Boosted Tumor Therapy
Yanrong Qian, Man Wang, Yulin Xie, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 32
Closed Access | Times Cited: 11
Self‐Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer
Jiaxing Pan, Yi Lai, Shunan Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 47
Closed Access | Times Cited: 11
Charting a Path to Tumor Therapy: Mastery of Luminescent Metal–Organic Frameworks for Precise Spatiotemporal Control
Renchi Gao, Tianxing Xu, Zhao Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 45
Closed Access | Times Cited: 4
Personalized Nanovaccine Based on STING-Activating Nanocarrier for Robust Cancer Immunotherapy
Yongjuan Li, Ya Dong, Danyang Shen, et al.
ACS Nano (2025)
Closed Access
Genetically Engineered Hematopoietic Stem Cells Deliver TGF‐β Inhibitor to Enhance Bone Metastases Immunotherapy
Beilei Wang, Jinyu Bai, Bo Tian, et al.
Advanced Science (2022) Vol. 9, Iss. 28
Open Access | Times Cited: 18

Scroll to top